CENTOGENE Expands Multiomic Diagnostic Portfolio With
Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology...
Stay updated with breaking news from Insight Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial PerformanceFirst half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth...
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue growth between 10%
Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould predict clinical course of patients and improve personalized care CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2023 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data confirming the